Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Wednesday, August 5, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Eyes on Washington: Federal Health Care Grant Notification Service

 

Grant Opportunities for July 27, 2015 through August 3, 2015

 

Visit Holland & Knight online

  

New Federal Health Care Grant Opportunities Announced for:

·         Centers for Disease Control and Prevention (CDC)

·         Food and Drug Administration (FDA)

·         Health Resources and Services Administration (HRSA)

·         US Army Medical Research Acquisition Activity (USAMRAA)

·         National Institutes of Health (NIH)

 

NON-NIH Funding Opportunity Announcements:

 

CDC: PPHF 2015: Nutrition, Physical Activity

Funding Opportunity Number: RFA-DP-15-008

The PRC Program was established by Congress in 1984 (Public Law 98-551) to conduct research in health promotion, disease prevention, and methods of appraising health hazards and risk factors. Congress mandated that the centers be located at academic health centers capable of providing multidisciplinary faculties with expertise in public health, relationships with professionals in other relevant fields, graduate training and demonstrated curricula in disease prevention, and a capability for residency training in public health or preventive medicine. This funding opportunity was announced on July 27, 2015. The application deadline is August 27, 2015. For more information, please visit CDC’s Full Funding Opportunity Announcement.

 

FDA: Evaluating Quality Metrics for Risk-Based Surveillance of Drug Manufacturing Operations and Facilities (U01)

Funding Opportunity Number: RFA-FD-16-004

The goal of this project is to evaluate a set of potential quality metrics for their utility in monitoring quality across the pharmaceutical manufacturing sector. This project aids to support FDA's efforts in transforming quality oversight from a qualitative to a quantitative and expertise-based assessment in order to assure that quality drugs are available to the American public. The outcomes of the project could also be used to assist in the development of a risk-based inspection approach for domestic and foreign drug establishments. This funding opportunity was announced on July 31, 2015. The application deadline is October 16, 2015. For more information, please visit FDA’s Full Funding Opportunity Announcement.

 

FDA: Building towards Statistically-Based Pharmaceutical Quality Standards (U01)

Funding Opportunity Number: RFA-FD-16-003

The goal of this project is to generate data and develop a statistical sampling and analysis strategy to aid FDA/CDER policy in drafting data-based guidance in support of the use of appropriate statistical tools and standards. Specifically, the development of standards for statistical methods suitable for lot release which could be used to drive industry towards increased product and process understanding throughout the lifecycle of a product. The project will provide data, sampling and data analysis approaches to inform for the agency and the human pharmaceutical industry to advance the development of risk- and science-based standards. These projects could be split into subsets by product type, process type, manufacturing complexity and/or therapeutic index to facilitate understanding. This funding opportunity was announced on July 31, 2015. The application deadline is October 16, 2015. For more information, please visit FDA’s Full Funding Opportunity Announcement.

 

HRSA: Service Area Competition

Funding Opportunity Number: HRSA-16-005

This funding opportunity announcement (FOA) solicits applications for the Health Center Program’s Service Area Competition (SAC).  The Health Center Program supports patient-directed public and private nonprofit organizations that provide primary and preventive health care services to the Nation’s medically underserved.  The purpose of the SAC funding opportunity is to ensure continued access to comprehensive, culturally competent, quality primary health care services for communities and vulnerable populations served by the Health Center Program.  This FOA details the SAC eligibility requirements, review criteria, and awarding factors for organizations seeking a grant for operational support to provide primary and preventive health care services to an announced service area under the Health Center Program. This funding opportunity was announced on July 28, 2015. The application deadline is September 28, 2015. For more information, please visit HRSA’s Full Funding Opportunity Announcement.

 

HRSA: Substance Abuse Service Expansion

Funding Opportunity Number: HRSA-16-074

This announcement solicits applications for Fiscal Year (FY) 2016 Substance Abuse Service Expansion. The purpose of this Health Center Program supplemental funding opportunity is to improve and expand the delivery of substance abuse services at existing health centers, with a focus on Medication-assisted Treatment (MAT) in opioid use disorders. This funding opportunity was announced on July 30, 2015. The application deadline is September 28, 2015. For more information, please visit HRSA’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD DMRDP JPC-1/MSIS

Funding Opportunity Number: W81XWH-15-DMRDP-MSIS-ATUMN

The FY16 JPC-1/MSIS ATUMN is seeking research, development, and testing on compensatory/adaptive medical tutor prototype(s). This includes evidence-based sustained learning methodologies that decrease the need for future technology dependence to retain the details of the cognitive processes that assist with patient assessment, clinical reasoning, clinical judgment, and clinical diagnosis and treatment. The tutor must accurately and appropriately understand where the learner is within the learning curve versus the course curricula, objectives, and anticipated outcomes, and understand where the learner needs to go versus the course curricula, objectives, and anticipated outcomes. The tutor must identify viable and course-appropriate route(s) on how to navigate from current position to end position. The proposed tutor needs to continuously evaluate the progress and re-plan/re-route as appropriate versus the course curricula, objectives, and anticipated outcomes. This funding opportunity was announced on July 29, 2015. The application deadline is December 17, 2015. For more information, please visit USAMRRA’s Full Funding Opportunity Announcement.

 

NIH Funding Opportunity Announcements:

 

NIH: Research to Advance Vaccine Safety (R01) & (R21)

Funding Opportunity Number: PA-15-312 (R01) PA-15-313 (R21)

The purpose of this funding opportunity announcement (FOA) is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity encourages studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems or healthcare databases, or 5) the application of genomic/molecular technologies and systems biology approaches to evaluate vaccine safety. R01 grants support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. R21 grants encourage the development of new research activities in categorical program areas. (Support generally is restricted in level of support and in time.) These funding opportunities were announced on July 28, 2015. The R01 initial application deadline is October 5, 2015. The R21 grant initial application deadline is October 16, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement (R01 & R21).

 

NIH: Discovery of Genetic Basis of Monogenic Heart, Lung, Blood, and Sleep Disorders (X01)

Funding Opportunity Number: PAR-15-314

This Funding Opportunity Announcement (FOA) invites applications to use the genome-wide sequencing capacity of the Centers for Mendelian Genomics to carry out studies of the genetic basis of Mendelian or monogenic disorders that significantly affect heart, lung, blood, and sleep (HLBS) systems. The studies facilitated by this Funding Opportunity Announcement (FOA) must have existing genomic DNA samples collected from patients with suspected Mendelian or monogenic disorders and propose to use the whole exome sequencing (WES) or whole genome sequencing (WGS) capacity of the Centers of Mendelian Genomics funded under RFA-HG-15-002. No funds will be provided to collect samples or conduct analyses. Applications must focus on heart, lung, blood, and sleep (HLBS) disorders likely influenced by genetic variant(s) in a single gene. This funding opportunity was announced on July 29, 2015. The initial application deadline is October 20, 2015. A letter of intent is due 30 days prior to the application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Alzheimer's Disease Translational Center for Disease Model Resources (U54)

Funding Opportunity Number: RFA-AG-16-014

This Funding Opportunity Announcement (FOA) invites U54 Cooperative Agreement applications aiming to establish an Alzheimers Disease Translational Center for Disease Model Resources. The purpose of the Center is to: develop the next generation of rodent animal models of AD; conduct extensive characterization and clinico-pathological staging of AD animal models using translatable biomarkers; develop translatable pharmacodynamic biomarkers for well validated therapeutic targets; develop and implement guidelines for standardized best practices for the rigorous preclinical testing of AD candidates; and conduct preclinical testing of candidate AD therapeutics and transparent reporting. This funding opportunity was announced on July 29, 2015. A letter of intent is due December 11, 2015. The application deadline is January 11, 2016. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Type 1 Diabetes Pathfinder Award (DP2)

Funding Opportunity Number: RFA-DK-15-030

The Type 1 Diabetes Pathfinder Award (DP2) was first initiated in 2008 as part of the Strategic Plan for Type 1 Diabetes Research.The goal is to support a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research relevant to type 1 diabetes and its complications. The Type 1 Diabetes Pathfinder Award initiative complements ongoing efforts by NIH and its Institutes and Centers to fund early stage investigators through R01 grants, which continue to be the major sources of NIH support for early stage investigators. The research proposed need not be in a conventional biomedical or behavioral discipline but must be relevant to type 1 diabetes. This funding opportunity was announced on July 29, 2015. A letter of intent is due January 17, 2016. The application deadline is February 17, 2016. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Limited Competition for the Renewal of the National Cell Repository of Alzheimer's Disease

Funding Opportunity Number: PAR-15-316

The National Institute on Aging invites applications to renew an ongoing NIA-supported cooperative agreement, the National Cell Repository for Alzheimer's disease. NCRAD was established in 1990 to recruit, collect, maintain and distribute information and biological specimens on large numbers of genetically informative, phenotypically well-characterized families having multiple individuals affected with AD. Initial efforts were focused on the recruitment of early onset, autosomal dominant families. Subsequently, NCRAD expanded its focus to include late onset families as well as kindred with familial non-AD dementia, such as the Fronto-temporal Disorders. This funding opportunity was announced on July 31, 2015. A letter of intent is due December 25, 2015. The initial application deadline is January 25, 2016. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Pelvic Floor Disorders Network Data Coordinating Center (U24) & (UG1)

Funding Opportunity Number: RFA-HD-16-011 (U24) & RFA-HD-16-012 (UG1)

This funding opportunity announcement (FOA) invites applications from institutions/organizations willing to participate with the NICHD in an ongoing multicenter clinical program designed to study clinical and health aspects of pelvic floor disorders in women.Pelvic floor disorders for the purpose of this FOA include urinary incontinence, fecal incontinence, pelvic organ prolapse, and other sensory and emptying abnormalities of the lower urinary and gastrointestinal tracts.Clinical and health aspects of pelvic floor disorders include surgical and nonsurgical treatments, social and behavioral contributions, pharmacologic therapies, any outcomes from the broad array of treatments available, and prevention efforts, among others.Translational aims to explore etiology and pathophysiology may be incorporated to maximize the use of the well-defined clinical study populations. Particular attention will be paid to the development of innovative solutions to the challenging problems faced by women with pelvic floor disorders with the aim of reducing the burden of pelvic floor disorders for women and their families. UG1 grants support single project applications conducting clinical evaluation of various methods of therapy and/or prevention. U24 grants support research projects contributing to improvement of the capability of resources to serve biomedical research. These funding opportunities were announced July 31, 2015. Letters of intent for both types of grants are due October 10, 2015. The application deadlines for both are November 10, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement (U24 & UG1.)

 

NIH: BRAIN: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01)

Funding Opportunity Number: RFA-EB-15-006

This FOA solicits new theories, computational models, and statistical methods to derive understanding of brain function from complex neuroscience data. Approaches could include the creation of new theories, ideas, and conceptual frameworks to organize/unify data and infer general principles of brain function; new computational models to develop testable hypotheses and design/drive experiments; and new mathematical and statistical methods to support or refute a stated hypothesis about brain function, and/or assist in detecting features in complex brain data. It is expected that the approaches developed under this FOA will be made widely available to the neuroscience research community for their use and modification. This funding opportunity was announced on July 31, 2015. A letter of intent is due September 21, 2015. The application deadline is October 21, 2016. For more information, please visit NIH's Full Funding Opportunity Announcement.

 


Association Management Software Powered by YourMembership  ::  Legal